We are happy to announce that we are now offering genetic testing through Courtagen Diagnostics Lab. This is currently the most comprehensive test on the market. The company accepts most insurances options and works closely with the patient to resolve any issues surrounding insurance issues. The out of pocket cost to the patient will never exceed $100. 

Here at Rejuvenate Wellness Center, we are primarily using genetic testing as an additional tool for diagnostic testing. If you have symptoms of a disease that may be caused by genetic alterations, this test can reveal if you do indeed have a suspected disorder. Genetic testing is also invaluable for predictive testing as well as carrier testing. 

There are a number of tests administered in the complete comprehensive panel including testing for mitochondrial disorders, seizure disorders, metabolic disorders, neurodevelopmental disorders as well as a number of methylation SNP tests. Below are brief descriptions of each of these tests, all of which are included in the complete comprehensive panel. 

Mitochondrial dysfunction is an important part of the genetic component of many of the functional and dysautonomic (disease or malfunction of the autonomic nervous system that controls many functions in the body) conditions, including: Autism spectrum disorder, Chronic fatigue, Depression, Cyclic vomiting, Irritable bowel syndrome, migraines and other chronic pain syndromes. 

The developmental panel is a strong test for sussing out the root cause of DD/ID/ASD. Developmental Delay (DD), Intellectual Disability (ID), and Autism Spectrum Disorders (ASD) are neurodevelopmental disorders that are typically diagnosed in early childhood. Often diagnosis of such disorders is challenging due to the wide range of symptoms, severity, nonspecific presentation, potentially overlapping differential diagnoses, or a rare disorder. Understanding the specific underlying genetic component of these disorders facilitates a more direct approach to treatment. 

Courtagen’s lysoSEEK™ panel provides extensive genetic analysis and clinical interpretation of data generated by the complete sequencing of 94 genes associated with close to 60 metabolic disorders.  The test seeks out enzymatic deficiencies in the lysosomes, and looks at additional genes useful for differential diagnoses. While we do include all of these tests in the comprehensive panel, they lysosomal panel is geared towards finding the root cause of Developmental Delay, Corneal Clouding, Hepatoslenomegaly, Failure to Thrive, Seizures, Stiff Joints, Oral Findings, Recurrent Respiratory Infections, Dystosis Multiplex, Endocrine Dysfunction, Skeletal Abnormalities, Facial Dysmorphishm, Exaggerated Startle, Cardiovascular Abnormalities etc. 

Courtagen’s epiSEEK® Comprehensive Sequence Analysis test provides extensive genetic analysis and clinical interpretation of data generated by the complete sequencing of 471 genes associated with epileptic and seizure disorder phenotypes. The updated panel includes several recently published genes. Multiple categories of disorders from earlier panel designs were expanded, including inborn errors of metabolism, congenital disorders of glycosylation, peroxisomal biogenesis disorders, seizures related to intellectual disability, and drug metabolism.

For more information, check out www.Courtagen.com.